Multiparameter Phase I Trials: A Tool for Model-Based Development of Targeted Agent Combinations – Example of EVESOR Trial

Mevidette El-Madani, Emilie Hénin, Thibaud Lefort, Michel Tod, Gilles Freyer, Philippe Cassier, Pierre-Jean Valette, Claire Rodriguez-Lafrasse, Francoise Berger, Jérome Guitton, Joel Lachuer, Khemaies Slimane, Catherine Barrois, Benoit You

Open source

DOI
10.2217/fon.15.49
Published
2015-05
Container
Future Oncology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2217/fon.15.49,
  title = {Multiparameter Phase I Trials: A Tool for Model-Based Development of Targeted Agent Combinations – Example of EVESOR Trial},
  author = {Mevidette El-Madani and Emilie Hénin and Thibaud Lefort and Michel Tod and Gilles Freyer and Philippe Cassier and Pierre-Jean Valette and Claire Rodriguez-Lafrasse and Francoise Berger and Jérome Guitton and Joel Lachuer and Khemaies Slimane and Catherine Barrois and Benoit You},
  year = {2015},
  journal = {Future Oncology},
  doi = {10.2217/fon.15.49},
  url = {https://doi.org/10.2217/fon.15.49}
}

RIS

TY  - JOUR
TI  - Multiparameter Phase I Trials: A Tool for Model-Based Development of Targeted Agent Combinations – Example of EVESOR Trial
AU  - Mevidette El-Madani
AU  - Emilie Hénin
AU  - Thibaud Lefort
AU  - Michel Tod
AU  - Gilles Freyer
AU  - Philippe Cassier
AU  - Pierre-Jean Valette
AU  - Claire Rodriguez-Lafrasse
AU  - Francoise Berger
AU  - Jérome Guitton
AU  - Joel Lachuer
AU  - Khemaies Slimane
AU  - Catherine Barrois
AU  - Benoit You
PY  - 2015
JO  - Future Oncology
DO  - 10.2217/fon.15.49
UR  - https://doi.org/10.2217/fon.15.49
ER  - 

APA

El-Madani, M., Hénin, E., Lefort, T., Tod, M., Freyer, G., Cassier, P., Valette, P., Rodriguez-Lafrasse, C., Berger, F., Guitton, J., Lachuer, J., Slimane, K., Barrois, C., & You, B. (2015). Multiparameter Phase I Trials: A Tool for Model-Based Development of Targeted Agent Combinations – Example of EVESOR Trial. Future Oncology. https://doi.org/10.2217/fon.15.49

Source records